latest news releases from the newsroom
Northrop Grumman Corp.
Northrop Grumman Board Declares Quarterly Dividends
LOS ANGELES, Nov. 16, 2004 (PRIMEZONE) -- The board of directors of Northrop Grumman Corporation (NYSE: NOC) today declared a quarterly dividend of 23 cents per share on Northrop Grumman common stock, payable Dec. 11, 2004, to shareholders of record as of the close of business Nov. 29, 2004. The board also declared a dividend of $1.75 per share on the company's Series B convertible preferred stock, payable Jan. 18, 2005, to shareholders of record as of the close of business Jan. 4, 2005.
Northrop Grumman Corp.
Northrop Grumman Issues Shares to Complete Equity Security Units Purchase Contracts
NEW YORK -- Nov. 16, 2004 -- Northrop Grumman Corporation (NYSE: NOC) announced today the settlement of the purchase contracts associated with the equity security units issued by Northrop Grumman Corporation on Nov. 21, 2001. Each purchase contract was settled at a rate of 1.9171 shares of Northrop Grumman Corporation common stock, which resulted in the issuance of approximately 13.2 million common shares. Northrop Grumman received approximately $690 million in proceeds from the issuance, which it intends to use for general corporate purposes.
Parker Waichman Alonso LLP
Parker & Waichman, LLP and Seeger Weiss LLP File Suit Against Pfizer, Inc. Charging Bextra was Responsible for Cardiac Death
NEW YORK, Nov. 16, 2004 (PRIMEZONE) -- Parker & Waichman, LLP and Seeger Weiss LLP have filed a case in Supreme Court of the State of New York, County of New York against Pfizer, Inc (NYSE:PFE). The case is on behalf of the estate of a 46 year old New Jersey resident who died of a heart attack after using Bextra. The suit claims that Pfizer has not acted responsibly and has failed to adequately and timely warn consumers about the life-threatening side effects associated with Bextra. For more information on this suit and Bextra side effects please visit www.bextralegalhelp.com or www.yourlawyer.com/practice/contact.htm?topic=Bextra .
Silverado Financial, Inc.
Silverado Appoints Interim Chief Financial Officer
PLEASANTON, Calif., Nov. 16, 2004 (PRIMEZONE) -- Silverado Financial Inc. (OTCBB:SLVO) today announced that Albert Golusin has resigned as a member of the Board of Directors and Chief Financial Officer of Silverado Financial, effective November 15, 2004, in order to focus full-time on his position as CFO of SunnComm International, Inc. (SCMI).
Cardo Exercises Warrant and Makes Capital Gain of about SEK 40 Million
MALMO, Sweden, Nov. 16, 2004 (PRIMEZONE) -- Cardo has exercised the warrant that was received as part of the selling price on disposal of the Rail business area in September 2002. At the same time, Cardo has decided to sell the shares received to the new principal owner of the operation. The sale gives a capital gain of approximately SEK 40 million.
Smith & Nephew PLC
Timing of Smith & Nephew plc International Financial Reporting Standards 'IFRS' Presentation
LONDON, Nov. 16, 2004 (PRIMEZONE) -- Smith & Nephew plc (LSE:SN) (NYSE:SNN), the global medical technology business, will tomorrow, 17 November 2004, give a webcast presentation and teleconference on how its UK GAAP results, for 2003 and for the first three quarters of 2004, will be re-stated for comparison purposes when IFRS is adopted from 1 January 2005. This information is being presented to assist the investment community in assessing the impact of IFRS on the group.